Top Markets
Coin of the day
Park Ha Biological Technology Co., Ltd. Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd.

PHH
Rangering i aksjer #33161
Park Ha Biological Technology Co., Ltd., an investment holding firm, is... Park Ha Biological Technology Co., Ltd., an investment holding firm, is primarily engaged in the creation and development of skincare products within the People's Republic of China. The company's operations are divided into two core areas: direct product sales and a franchise service model. Under its own 'Park Ha' brand, the company offers a comprehensive selection of skincare solutions. These products cater to a spectrum of dermatological needs, ranging from fundamental physical skin protection and exfoliation to repairing the sebum film, achieving surface microecological balance, and providing anti-aging treatments. Park Ha Biological Technology distributes its merchandise to consumers through both its company-owned retail outlets and an extensive network of franchised partners. Established in 2016, the firm's main office is situated in Wuxi, PRC. It operates as a subsidiary of Xiaoqiu Holding Ltd.
Aksjekurs
$0.2527
Sist synkronisert: 2025-11-24
Markedsverdi
$8.25M
Endring (1 dag)
-1.98%
Endring (1 år)
-55.67%
Land
CN
Handel Park Ha Biological Technology Co., Ltd. (PHH)
Inntekter for Park Ha Biological Technology Co., Ltd. (PHH)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Park Ha Biological Technology Co., Ltd. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Park Ha Biological Technology Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$87.03B -
US
$51.67B -
FR
$21.05B -
US
$7.28B -
IN
$15.41B -
US